A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis

Arthritis Research and Therapy

Volumn 17, Issue 1, 2015, Pages

  van Steenbergen, Hanna W ^a   Rodríguez Rodríguez, Luis ^b   Berglin, Ewa ^c   Zhernakova, Alexandra ^d   Knevel, Rachel ^a   Ivorra Cortés, Jose ^e   Huizinga, Tom ^a   Fernández Gutiérrez, Benjamin ^b   Gregersen, Peter K ^f   Rantapää Dahlqvist, Solbritt ^c   van der Helm van Mil, Annette ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C5 TRAF1 PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; FC RECEPTOR; FC RECEPTOR LIKE 3; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; UNCLASSIFIED DRUG; ANTIIDIOTYPIC ANTIBODY; COMPLEMENT COMPONENT C5; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; FCRL3 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR;

ADULT; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENOTYPE; HUMAN; IMAGE ANALYSIS; JOINT INJURY; JOINT RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NETHERLANDS; NORTH AMERICA; RHEUMATOID ARTHRITIS; SPAIN; SWEDEN; BLOOD; CLINICAL TRIAL; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; JOINT; MULTICENTER STUDY; PATHOLOGY; RADIOGRAPHY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ARTHRITIS, RHEUMATOID; COMPLEMENT C5; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; JOINTS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; TNF RECEPTOR-ASSOCIATED FACTOR 1;

EID: 84924328152     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-014-0514-0     Document Type: Article

References (40)

1. Finckh A, Choi HK, Wolfe F. Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment. Ann Rheum Dis. 2006;65:1192-7.
2. Knevel R, Grondal G, Huizinga TW, Visser AW, Jonsson H, Vikingsson A, et al. Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: a population-based study. Ann Rheum Dis. 2012;71:707-9.
3. van Steenbergen HW, Tsonaka R, Huizinga TW, le Cessie S, van der Helm-van Mil AH. Predicting the severity of joint damage in rheumatoid arthritis. the contribution of genetic factors. Ann Rheum Dis. Published Online First 15 Jan 2014. doi:10.1136/annrheumdis-2013-204277.
4. Krabben A, Huizinga TW, van der Helm-van Mil AH. Biomarkers for radiographic progression in rheumatoid arthritis. Curr Pharm Des. 2014;21:147-69.
5. Marinou I, Healy J, Mewar D, Moore DJ, Dickson MC, Binks MH, et al. Association of interleukin-6 and interleukin-10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status. Arthritis Rheum. 2007;56:2549-56.
6. Huizinga TW, Keijsers V, Yanni G, Hall M, Ramage W, Lanchbury J, et al. Are differences in interleukin 10 production associated with joint damage? Rheumatology (Oxford). 2000;39:1180-8.
7. Cantagrel A, Navaux F, Loubet-Lescoulie P, Nourhashemi F, Enault G, Abbal M, et al. Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum. 1999;42:1093-100.
8. Plant D, Thomson W, Lunt M, Flynn E, Martin P, Eyre S, et al. The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register. Rheumatology (Oxford). 2011;50:78-84.
9. Viatte S, Plant D, Lunt M, Fu B, Flynn E, Parker BJ, et al. Investigation of rheumatoid arthritis genetic susceptibility markers in the early rheumatoid arthritis study further replicates the TRAF1 association with radiological damage. J Rheumatol. 2013;40:144-56.
10. Maehlen MT, Nordang GB, Syversen SW, van der Heijde DM, Kvien TK, Uhlig T, et al. FCRL3-169C/C genotype is associated with anti-citrullinated protein antibody-positive rheumatoid arthritis and with radiographic progression. J Rheumatol. 2011;38:2329-35.
11. Han SW, Sa KH, Kim SI, Lee SI, Park YW, Lee SS, et al. FCRL3 gene polymorphisms contribute to the radiographic severity rather than susceptibility of rheumatoid arthritis. Hum Immunol. 2012;73:537-42.
12. Choi CB, Kang CP, Seong SS, Bae SC, Kang C. The -169C/T polymorphism in FCRL3 is not associated with susceptibility to rheumatoid arthritis or systemic lupus erythematosus in a case-control study of Koreans. Arthritis Rheum. 2006;54:3838-41.
13. de Rooy DP, van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH. Predicting arthritis outcomes-what can be learned from the Leiden Early Arthritis Clinic? Rheumatology (Oxford). 2011;50:93-100.
14. Innala L, Kokkonen H, Eriksson C, Jidell E, Berglin E, Dahlqvst SR. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides. J Rheumatol. 2008;35:1002-8.
15. Rodriguez-Rodriguez L, Jover-Jover JA, Fontsere O, Pena-Blanco RC, Leon L, Fernandez-Gutierrez B, et al. Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: a survival analysis. Scand J Rheumatol. 2013;42:433-6.
16. Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002;359:1173-7.
17. Wolfe F, Michaud K. The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank. Rheumatology (Oxford). 2011;50:16-24.
18. Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med. 2007;357:1199-209.
19. Trynka G, Hunt KA, Bockett NA, Romanos J, Mistry V, Szperl A, et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet. 2011;43:1193-201.
20. de Rooy DP, Zhernakova A, Tsonaka R, Willemze A, Kurreeman BA, Trynka G, et al. A genetic variant in the region of MMP-9 is associated with serum levels and progression of joint damage in rheumatoid arthritis. Ann Rheum Dis. 2014;73:1163-9.
21. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22:1790-7.
22. Westra HJ, Peters MJ, Esko T, Yaghootkar H, Schurmann C, Kettunen J, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet. 2013;45:1238-43.
23. Raj T, Rothamel K, Mostafavi S, Ye C, Lee MN, Replogle JM, et al. Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science. 2014;344:519-23.
24. Nishimoto K, Kochi Y, Ikari K, Yamamoto K, Suzuki A, Shimane K, et al. Association study of TRAF1-C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese. Ann Rheum Dis. 2010;69:368-73.
25. Fairfax BP, Humburg P, Makino S, Naranbhai V, Wong D, Lau E, et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science. 2014;343:1246949.
26. Lee MN, Ye C, Villani AC, Raj T, Li W, Eisenhaure TM, et al. Common genetic variants modulate pathogen-sensing responses in human dendritic cells. Science. 2014;343:1246980.
27. Knevel R, Tsonaka R, le Cessie S, van der Linden MP, Huizinga TW, van der Heijde DM, et al. Comparison of methodologies for analysing the progression of joint destruction in rheumatoid arthritis. Scand J Rheumatol. 2013;42:182-9.
28. Kurreeman FA, Padyukov L, Marques RB, Schrodi SJ, Seddighzadeh M, Stoeken-Rijsbergen G, et al. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med. 2007;4:e278.
29. Knevel R, de Rooy DP, Gregersen PK, Lindqvist E, Wilson AG, Grondal G, et al. Studying associations between variants in TRAF1-C5 and TNFAIP3-OLIG3 and the progression of joint destruction in rheumatoid arthritis in multiple cohorts. Ann Rheum Dis. 2012;71:1753-5.
30. Han TU, Bang SY, Kang C, Bae SC. TRAF1 polymorphisms associated with rheumatoid arthritis susceptibility in Asians and in Caucasians. Arthritis Rheum. 2009;60:2577-84.
31. van der Helm-van Mil AH, Huizinga TW, Schreuder GM, Breedveld FC, de Vries RR, Toes RE. An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility. Arthritis Rheum. 2005;52:2637-44.
32. van der Linden MP, Feitsma AL, le Cessie S, Kern M, Olsson LM, Raychaudhuri S, et al. Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis. Arthritis Rheum. 2009;60:2242-7.
33. Knevel R, Krabben A, Brouwer E, Posthumus MD, Wilson AG, Lindqvist E, et al. Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study. Ann Rheum Dis. 2012;71:1651-7.
34. de Rooy DP, Yeremenko NG, Wilson AG, Knevel R, Lindqvist E, Saxne T, et al. Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis. Ann Rheum Dis. 2013;72:769-75.
35. Knevel R, de Rooy DP, Zhernakova A, Grondal G, Krabben A, Steinsson K, et al. Association of variants in IL2RA with progression of joint destruction in rheumatoid arthritis. Arthritis Rheum. 2013;65:1684-93.
36. Knevel R, Krabben A, Wilson AG, Brouwer E, Leijsma MK, Lindqvist E, et al. A genetic variant in granzyme B is associated with progression of joint destruction in rheumatoid arthritis. Arthritis Rheum. 2013;65:582-9.
37. Krabben A, Wilson AG, de Rooy DP, Zhernakova A, Brouwer E, Lindqvist E, et al. Association of genetic variants in the IL4 and IL4R genes with the severity of joint damage in rheumatoid arthritis: a study in seven cohorts. Arthritis Rheum. 2013;65:3051-7.
38. Knevel R, Klein K, Somers K, Ospelt C, Houwing-Duistermaat JJ, van Nies JA, et al. Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis. Ann Rheum Dis. 2014;73:2038-46.
39. Teare MD, Knevel R, Morgan MD, Kleszcz A, Emery P, Moore DJ, et al. Allele-dose association of the C5orf30 rs26232 variant with joint damage in rheumatoid arthritis. Arthritis Rheum. 2013;65:2555-61.
40. Knevel R, de Rooy DP, Saxne T, Lindqvist E, Leijsma MK, Daha NA. A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis. Arthritis Res Ther. 2014;16:R108.